Abnormal expression of CCDC in malignant tumors leads to cytoskeletal structural rearrangements, which activate intracellular signaling phospholipase C and mitogen-activated protein kinases to ultimately promote tumor cell migration and invasion [56]. Here, WNK2 is linked to cancer.